Established during 2000, the Nebraska Center for Virology (NCV;P20RR015635) is a multi-institutional, interdisciplinary center linking the virology expertise and resources at Nebraska's major biomedical research institutions: the University of Nebraska-Lincoln, the University of Nebraska Medical Center, and Creighton University. NCV investigators study human, animal, and plant viruses;their collective expertise presents a national strength and an exceptional opportunity to collaborate on model systems expected to lead to new approaches to understand and treat diseases threatening human health and economic well-being. Following nine years of COBRE program support, the NCV is developing a global research and training presence, and establishing an interdisciplinary research program addressing fundamental questions about infectious agents and their host interactions and creating an environment that is producing a new generation of innovative researchers with a broad knowledge of virology. COBRE support has allowed the Center to establish a critical mass of focused virology expertise and resources on each participating campus;however, to become an independent center, the NCV must bolster its interdisciplinary and cross-campus collaborations and implement a sustainability plan for its core facilities. In addition, several promising junior faculty conducting highly meritorious research continue to need NCV support and mentoring to gain independence. Additional capacity built through Phase III COBRE funding will enable the NCV to realize its strategic plan and achieve its long-term vision: to become an internationally recognized center of research excellence, with outstanding core facilities that serve IDeA, regional, and international scientific communities. This vision will be realized by completing three specific aims: 1) increase the research productivity and external funding potential of NCV faculty by continuing an effective mentoring program for junior faculty, sponsoring a pilot project program, and continuing support for four essential core facilities (administrative, flow cytometry, microscopy, and proteomics);2) strengthen the NCV's focus on translational research and virology research training and education through new partnerships and programs to share viral immunology and molecular virology expertise and scientific resources with researchers, clinicians, and students globally;and 3) emerge from COBRE Phase III funding as a self-sustaining center of research excellence in virology by diversifying the NCV's external research funding portfolio through increased individual-investigator and collaborative grant productivity.

Public Health Relevance

Phase III COBRE funding will ideally position the Nebraska Center for Virology to provide the infrastructure support needed to increase understanding of the molecular mechanisms by which different viral agents establish persistent infection, interact with the host, are transmitted from one host to another, and cause disease - with the ultimate goal of contributing to new strategies to treat and prevent such infections.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Program Officer
Zlotnik, Hinda
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Nebraska Lincoln
Schools of Arts and Sciences
United States
Zip Code
Milrot, Elad; Shimoni, Eyal; Dadosh, Tali et al. (2017) Structural studies demonstrating a bacteriophage-like replication cycle of the eukaryote-infecting Paramecium bursaria chlorella virus-1. PLoS Pathog 13:e1006562
Liu, Jianuo; Xu, Enquan; Tu, Guihua et al. (2017) Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current. Mol Cell Neurosci 82:167-175
Welch-Lazoritz, Melissa; Habecker, Patrick; Dombrowski, Kirk et al. (2017) Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico. Int J Drug Policy 43:16-22
Shahnaz, Gul; Edagwa, Benson J; McMillan, JoEllyn et al. (2017) Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomedicine (Lond) 12:99-115
Loy, John Dustin; Clawson, Michael L (2017) Rapid typing of Mannheimia haemolytica major genotypes 1 and 2 using MALDI-TOF mass spectrometry. J Microbiol Methods 136:30-33
Poppe, Lisa K; Chunda-Liyoka, Catherine; Kwon, Eun Hee et al. (2017) HIV drug resistance in infants increases with changing PMTCT regimens. AIDS :
Speciale, Immacolata; Agarkova, Irina; Duncan, Garry A et al. (2017) Structure of the N-glycans from the chlorovirus NE-JV-1. Antonie Van Leeuwenhoek 110:1391-1399
Lee, Chang-Won; Osorio, Fernando A; Woolums, Amelia R (2017) Preface. Vet Microbiol 206:1-2
Coronado-GarcĂ­a, Mayra; Thrash, Courtney R; Welch-Lazoritz, Melissa et al. (2017) Using Network Sampling and Recruitment Data to Understand Social Structures Related to Community Health in a Population of People Who Inject Drugs in Rural Puerto Rico. P R Health Sci J 36:77-83
Gendelman, Howard E; Zhang, Yuning; Santamaria, Pamela et al. (2017) Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial. NPJ Parkinsons Dis 3:10

Showing the most recent 10 out of 239 publications